SOFOSBUVIR/VELPATASVIR FIXED DOSE COMBINATION FOR 12 WEEKS IN HCV INFECTED PATIENTS PREVIOUSLY TREATED WITH PLACEBO: RESULTS OF THE DEFERRED TREATMENT STUDY (GS-US-342-1446 STUDY)

T Asselah, S Shafran, S Bourgeois, C-L Lai, M Cramp, P Mathurin, B Willems, MH Nguyen, MN Davis, KC Huang, E Svarovskaia, A Osinusi, J Mcnally, D Brainard, J McHutchison, OS Shaikh, TT Tran

Research output: Contribution to journalConference proceedings published in a journalpeer-review

Original languageEnglish
Pages (from-to)S827-S828
Number of pages0
JournalJournal of Hepatology
Volume64
Issue number0
Publication statusPublished - 2016

Cite this